COURAGE CAPITAL MANAGEMENT LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 41 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
COURAGE CAPITAL MANAGEMENT LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$130,000
-85.1%
75,000
-50.0%
0.10%
-78.6%
Q3 2018$870,000
-16.3%
150,050
-38.3%
0.47%
-39.4%
Q2 2018$1,040,000
-8.0%
243,000
+26.2%
0.78%
-9.9%
Q1 2018$1,130,000
+22.3%
192,486
-3.8%
0.86%
+30.4%
Q4 2017$924,000
-15.8%
200,0000.0%0.66%
-10.1%
Q3 2017$1,098,000
-4.7%
200,0000.0%0.74%
+24.2%
Q2 2017$1,152,000
+59.8%
200,000
+60.0%
0.59%
-0.2%
Q1 2017$721,000
+36.8%
125,000
+25.0%
0.59%
+81.9%
Q4 2016$527,000
+163.5%
100,0000.0%0.33%
+323.4%
Q3 2016$200,000100,0000.08%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders